1 – 13 of 13
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials
(
- Contribution to journal › Article
- 2007
-
Mark
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
(
- Contribution to journal › Article
-
Mark
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
(
- Contribution to journal › Article
- 2006
-
Mark
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
(
- Contribution to journal › Article
- 2005
-
Mark
Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Chlamydial antibodies and risk of prostate cancer
(
- Contribution to journal › Article
-
Mark
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
(
- Contribution to journal › Article
- 2004
-
Mark
Metabolism of 25-hydroxyvitamin D-3 may explain the U-shaped risk curve for prostate cancer
(
- Contribution to journal › Letter
-
Mark
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
(
- Contribution to journal › Article
- 2002
-
Mark
Preventive human papillomavirus vaccination.
(
- Contribution to journal › Article
-
Mark
A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
(
- Contribution to journal › Article
-
Mark
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.
(
- Contribution to journal › Article
- 1996
-
Mark
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
(
- Contribution to journal › Article